Search results
Results from the WOW.Com Content Network
The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom.It is an annually published collection of quality standards for medicinal substances in the UK, which is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.
The 1699 Edinburgh Pharmacopoeia. A pharmacopoeia, pharmacopeia, or pharmacopoea (from the obsolete typography pharmacopœia, meaning "drug-making"), in its modern technical sense, is a book containing directions for the identification of compound medicines, and published by the authority of a government or a medical or pharmaceutical society.
In the 142 years from initial publication to the merging into the British Pharmacopoeia, the Edinburgh Pharmacopoeia had twelve acknowledged editions, the last two in English. [2] Opposition to revision argued that it made the pharmacopoeia appear unstable but proponents argued it kept the pharmacopoeia relevant with scientific and medical ...
The Pharmaceutical Society of Great Britain was founded on 15 April 1841 [1] by William Allen FRS, Jacob Bell, Daniel Hanbury, John Bell, Andrew Ure, James Marwood Hucklebridge, and other London chemists and druggists, at a meeting in the Crown and Anchor Tavern, Strand, London.
The 1934 edition was described by the British Medical Journal as "one of the most useful reference books available to the medical profession". [ 1 ] In 1963 Edward G Feldmann, director of revision for the US National Formulary, described it as "a compilation of highly authoritative and useful therapeutic (actions and doses) information as well ...
A British Approved Name (BAN) is the official, non-proprietary, or generic name given to a pharmaceutical substance, as defined in the British Pharmacopoeia (BP). [1] The BAN is also the official name used in some countries around the world, because starting in 1953, proposed new names were evaluated by a panel of experts from WHO in conjunction with the BP commission to ensure naming ...
The Northern British (Scottish) branch began the same year with nine founders including William Flockhart and John Duncan. [3] From 1843, it had a royal charter that identified its chief objectives as the advancement of chemistry and pharmacy, the promotion of a system of education for its practitioners, and the legal protection of its members. [4]
Manage the Clinical Practice Research Datalink and the British Pharmacopoeia. The MHRA hosts and supports a number of expert advisory bodies, including the British Pharmacopoeia Commission, and the Commission on Human Medicine which replaced the Committee on the Safety of Medicines in 2005. [citation needed]